Blair William & Co. IL Cuts Holdings in Shire PLC (SHPG)

Blair William & Co. IL decreased its holdings in shares of Shire PLC (NASDAQ:SHPG) by 23.4% during the first quarter, according to its most recent filing with the SEC. The firm owned 3,556 shares of the biopharmaceutical company’s stock after selling 1,088 shares during the period. Blair William & Co. IL’s holdings in Shire were worth $531,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of SHPG. Sei Investments Co. increased its position in Shire by 22.0% during the 4th quarter. Sei Investments Co. now owns 36,017 shares of the biopharmaceutical company’s stock valued at $5,588,000 after purchasing an additional 6,489 shares during the period. UBS Asset Management Americas Inc. increased its position in Shire by 15.0% during the 4th quarter. UBS Asset Management Americas Inc. now owns 176,992 shares of the biopharmaceutical company’s stock valued at $27,455,000 after purchasing an additional 23,030 shares during the period. Baird Financial Group Inc. increased its position in Shire by 43.1% during the 4th quarter. Baird Financial Group Inc. now owns 2,358 shares of the biopharmaceutical company’s stock valued at $366,000 after purchasing an additional 710 shares during the period. State of Tennessee Treasury Department purchased a new position in Shire during the 4th quarter valued at about $4,731,000. Finally, Brown Advisory Inc. increased its position in Shire by 350.7% during the 4th quarter. Brown Advisory Inc. now owns 10,525 shares of the biopharmaceutical company’s stock valued at $1,632,000 after purchasing an additional 8,190 shares during the period. 17.90% of the stock is currently owned by institutional investors and hedge funds.

A number of research analysts have commented on the stock. Kepler Capital Markets reissued a “buy” rating on shares of Shire in a research report on Friday, May 11th. BTIG Research reissued a “buy” rating and set a $195.00 target price on shares of Shire in a research report on Sunday, April 29th. Royal Bank of Canada reissued a “buy” rating on shares of Shire in a research report on Tuesday, May 8th. B. Riley raised their target price on shares of Shire to $200.00 and gave the company a “buy” rating in a research report on Thursday, April 19th. Finally, Zacks Investment Research raised shares of Shire from a “sell” rating to a “hold” rating in a research report on Monday, April 23rd. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and twelve have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $201.64.

Shares of Shire stock opened at $161.75 on Tuesday. The company has a current ratio of 1.14, a quick ratio of 0.66 and a debt-to-equity ratio of 0.45. Shire PLC has a 52-week low of $123.73 and a 52-week high of $177.51. The company has a market capitalization of $49.20 billion, a PE ratio of 10.68, a PEG ratio of 1.34 and a beta of 1.29.

Shire (NASDAQ:SHPG) last released its earnings results on Thursday, April 26th. The biopharmaceutical company reported $3.86 EPS for the quarter, topping analysts’ consensus estimates of $3.58 by $0.28. The company had revenue of $3.77 billion during the quarter. Shire had a net margin of 28.96% and a return on equity of 13.60%. The firm’s revenue for the quarter was up 5.4% on a year-over-year basis. During the same quarter last year, the business earned $3.63 earnings per share. equities research analysts expect that Shire PLC will post 15.27 earnings per share for the current fiscal year.

Shire Profile

Shire plc, a biotechnology company, researches, develops, licenses, manufactures, markets, distributes, and sells medicines for rare diseases and other specialized conditions worldwide. The company offers products in therapeutic areas, including hematology, genetic diseases, neuroscience, immunology, internal medicine, ophthalmology, and oncology.

Want to see what other hedge funds are holding SHPG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Shire PLC (NASDAQ:SHPG).

Institutional Ownership by Quarter for Shire (NASDAQ:SHPG)

Receive News & Ratings for Shire Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply